更新为: 晚期胆道癌症系统治疗的新进展
Chigusa Morizane1, Makoto Ueno2, Masafumi Ikeda3
1Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Japanese journal of clinical oncology
|February 4, 2025
概括
晚期胆道癌症现在已经改善了第一线治疗选择,在化疗中添加了免疫检查点抑制剂,显著延长了生存时间. 针对性疗法也在出现,用于后期治疗.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆道癌 (BTC),包括胆囊癌,囊癌和肝内胆道癌,经常在晚期被诊断为癌症.
- 晚期BTC的传统治疗依赖于细胞毒性化疗方案.
研究的目的:
- 审查晚期胆道癌症系统治疗的最新进展.
- 突出更新的第一线和第二线治疗策略以及新兴的向疗法.
主要方法:
- 审查当前的临床实践指南和先进的BTC治疗的最新临床试验数据.
- 对免疫疗法,标准化疗和向药物的疗效数据的分析.
主要成果:
- 首线治疗:结合免疫检查点抑制剂 (杜尔瓦卢马布或潘布罗利祖马布) 的吉姆西塔加西斯,与单独使用吉姆西塔加西斯相比,整体存活率有所改善.
- 二线疗法:甲,叶酸和甲仍然是基于gemcitabine的治疗方案后的标准二线选择.
- 向性疗法:向FGFR2融合,IDH1/2,KRAS,BRAF突变和HER2过度表达的药物在后一线设置中显示出前景.
结论:
- 免疫检查点抑制剂组合代表了先进BTC的第一线治疗的新标准,改善了患者的治疗结果.
- 向疗法为高级BTC中的特定分子变化提供了新的治疗途径,扩大了化学疗法之外的治疗选择.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:27Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464